The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mora, A. L.
Right arrow Articles by Boothby, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mora, A. L.
Right arrow Articles by Boothby, M.
The Journal of Immunology, 2001, 166: 2218-2227.
Copyright © 2001 by The American Association of Immunologists

NF-{kappa}B/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells1

Ana L. Mora*, Jeehee Youn2,*, Achsah D. Keegan{dagger} and Mark Boothby3,*

* Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, TN 37232; and {dagger} Immunology Department, Holland Labs, American Red Cross, Bethesda, MD 20855

Proliferative responses of lymphoid cells to IL-2 and IL-4 depend on activation of the cells, but the mechanism(s) by which activation enhances cellular competence to respond to cytokines is not fully understood. The NF-{kappa}B/Rel family represents one signal transduction pathway induced during such activation. We show in this study that inhibition of NF-{kappa}B through the expression of an I{kappa}B{alpha} (inhibitory protein that dissociates from NF-{kappa}B) mutant refractory to signal-induced degradation (I{kappa}B{alpha}({Delta}N)) interfered with the acquisition of competence to proliferate in response to IL-4 as well as IL-2. Thymocytes and T cells from I{kappa}B{alpha}({Delta}N) transgenic mice expressed normal levels of IL-2R subunits. However, transgenic cells exhibited a dramatic defect in Stat5A activation treatment with IL-2, and a similar defect was observed for IL-4-induced Stat5. In contrast, T lymphoid cells with inhibition of NF-{kappa}B showed normal insulin receptor substrate-2 phosphorylation and only a modest decrease in Stat6 activation and insulin receptor substrate-1 phosphorylation after IL-4 stimulation. These results indicate that the NF-{kappa}B/Rel/I{kappa}B{alpha} system can regulate cytokine receptor capacitation through effects on the induction of downstream signaling by the Stat transcription factor family.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Song, T. So, and M. Croft
Activation of NF-{kappa}B1 by OX40 Contributes to Antigen-Driven T Cell Expansion and Survival
J. Immunol., June 1, 2008; 180(11): 7240 - 7248.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
F. Zhang and M. Boothby
T helper type 1-specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-{gamma} promoter are Stat4 dependent
J. Exp. Med., June 12, 2006; 203(6): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. M. Tato, N. Mason, D. Artis, S. Shapira, J. C. Caamano, J. H. Bream, H.-C. Liou, and C. A. Hunter
Opposing roles of NF-{kappa}B family members in the regulation of NK cell proliferation and production of IFN-{gamma}
Int. Immunol., April 1, 2006; 18(4): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H. Lu, W. Ouyang, and C. Huang
Inflammation, a Key Event in Cancer Development
Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Stephenson, D.-S. Park, A. L. Mora, S. Goenka, and M. Boothby
Sequence Motifs in IL-4R{alpha} Mediating Cell-Cycle Progression of Primary Lymphocytes
J. Immunol., October 15, 2005; 175(8): 5178 - 5185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. L. Mora, J. LaVoy, M. McKean, A. Stecenko, K. L. Brigham, R. Parker, and M. Rojas
Prevention of NF-{kappa}B activation in vivo by a cell-permeable NF-{kappa}B inhibitor peptide
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L536 - L544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Mason, H.-C. Liou, and C. A. Hunter
T Cell-Intrinsic Expression of c-Rel Regulates Th1 Cell Responses Essential for Resistance to Toxoplasma gondii
J. Immunol., March 15, 2004; 172(6): 3704 - 3711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Corn, M. A. Aronica, F. Zhang, Y. Tong, S. A. Stanley, S. R. A. Kim, L. Stephenson, B. Enerson, S. McCarthy, A. Mora, et al.
T Cell-Intrinsic Requirement for NF-{kappa}B Induction in Postdifferentiation IFN-{gamma} Production and Clonal Expansion in a Th1 Response
J. Immunol., August 15, 2003; 171(4): 1816 - 1824.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Mora, L. M. Stephenson, B. Enerson, J. Youn, A. D. Keegan, and M. Boothby
New Programming of IL-4 Receptor Signal Transduction in Activated T Cells: Stat6 Induction and Th2 Differentiation Mediated by IL-4R{alpha} Lacking Cytoplasmic Tyrosines
J. Immunol., August 15, 2003; 171(4): 1891 - 1900.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Pieper, V. Nilakantan, G. Hilton, N. L. N. Halligan, C. C. Felix, B. Kampalath, A. K. Khanna, A. M. Roza, C. P. Johnson, and M. B. Adams
Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1542 - H1551.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Tato, A. Villarino, J. H. Caamano, M. Boothby, and C. A. Hunter
Inhibition of NF-{kappa}B Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-{gamma} Required for Resistance to Toxoplasma gondii
J. Immunol., March 15, 2003; 170(6): 3139 - 3146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, K. Speirs, K. Joyce, M. Goldschmidt, J. Caamano, C. A. Hunter, and P. Scott
NF-{kappa}B1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major
J. Immunol., February 15, 2003; 170(4): 1995 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Kang, H. S. Lee, H. J. Jung, H. J. Kim, J. S. Hah, and V. Castranova
Inhibition of Mitogenic Stimulant-Induced Activation of Thymocytes with Zinc Tetrakis-(N-Methyl-4'-Pyridyl) Porphyrinato
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Caamano and C. A. Hunter
NF-{kappa}B Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Clin. Microbiol. Rev., July 1, 2002; 15(3): 414 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Li, X. Qi, M. Williams, Y. Shi, and A. D. Keegan
Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death
J. Immunol., June 15, 2002; 168(12): 6215 - 6223.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Zamorano, A. L. Mora, M. Boothby, and A. D. Keegan
NF-{kappa}B activation plays an important role in the IL-4-induced protection from apoptosis
Int. Immunol., December 1, 2001; 13(12): 1479 - 1487.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.